0001181431-12-040546.txt : 20120712
0001181431-12-040546.hdr.sgml : 20120712
20120712163235
ACCESSION NUMBER: 0001181431-12-040546
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120710
FILED AS OF DATE: 20120712
DATE AS OF CHANGE: 20120712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRIEDMAN PAUL A
CENTRAL INDEX KEY: 0001236927
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 12959593
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION
STREET 2: 3160 PORTER DRIVE
CITY: PALO LATO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
rrd350691.xml
X0306
4
2012-07-10
0
0000879169
INCYTE CORP
INCY
0001236927
FRIEDMAN PAUL A
EXPERIMENTAL STATION
ROUTE 141 & HENRY CLAY ROAD
WILMINGTON
DE
19880
1
1
0
0
Chief Executive Officer
Common Stock
2012-07-10
4
M
0
5556
3.11
A
315263
D
Common Stock
2012-07-10
4
M
0
6480
8.99
A
321743
D
Common Stock
2012-07-10
4
M
0
834
8.99
A
322577
D
Common Stock
2012-07-10
4
M
0
10441
8.64
A
333018
D
Common Stock
2012-07-10
4
M
0
1875
8.64
A
334893
D
Incentive Stock Option (right to buy)
3.11
2012-07-10
4
M
0
5556
0
D
2016-01-26
Common Stock
5556
0
D
Incentive Stock Option (right to buy)
8.99
2012-07-10
4
M
0
6480
0
D
2015-01-17
Common Stock
6480
0
D
Incentive Stock Option (right to buy)
8.99
2012-07-10
4
M
0
834
0
D
2015-01-17
Common Stock
834
0
D
Incentive Stock Option (right to buy)
8.64
2012-07-10
4
M
0
10441
0
D
2014-02-26
Common Stock
10441
0
D
Incentive Stock Option (right to buy)
8.64
2012-07-10
4
M
0
1875
0
D
2014-02-26
Common Stock
1875
0
D
Beginning January 27, 2009, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning January 18, 2005, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Beginning February 27, 2004, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
/s/ Paul A. Friedman
2012-07-12